Images are for illustrative purposes only. Packaging may vary.
Research material provided with clear specifications and available analytical documentation.
Contact us for product details, availability, or bulk inquiries.
A dual GIP / GLP-1 receptor agonist studied in glucose regulation, insulin sensitivity and metabolic physiology.
Tirzepatide is listed in the EULIX Research catalog as a 30 mg research compound.
Review the product identity, presentation and batch documentation together when consulting analytical documentation.
For laboratory research and analytical purposes only. Not for human or veterinary use.
Available analytical documentation identifies a specific sample. Review the published report for:
Laboratory reports require a confirmed match to the supplied batch. Review the available documents using the COA / Lab Report button.
Search independent scientific sources for Tirzepatide. Published research does not validate this product or its batch.
References checked September 9, 2026. Recent relevant publications are prioritized. Research does not validate EULIX materials or batches.
Study in early type 2 diabetes. Annals of Internal Medicine, July 2026.
Read publicationMaintenance study in people with obesity. The Lancet, June 2026.
Read publication
